Mycobacterial ATP synthase — Drug Target

All drugs that target Mycobacterial ATP synthase — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

ATP synthase inhibitor

Marketed (1)

• Bedaquiline (B) · Shenzhen Third People's Hospital · ATP synthase inhibitor · Infectious Disease
  Bedaquiline inhibits bacterial ATP synthase, disrupting energy production in Mycobacterium tuberculosis.

Phase 3 pipeline (2)

• Bedaquiline Oral Tablet · Wits Health Consortium (Pty) Ltd · ATP synthase inhibitor · Infectious Disease
  Bedaquiline inhibits bacterial ATP synthase, disrupting energy production in Mycobacterium tuberculosis.
• BE-PEP Bedaquiline · Institute of Tropical Medicine, Belgium · ATP synthase inhibitor · Infectious Disease
  Bedaquiline inhibits bacterial ATP synthase, disrupting energy production in Mycobacterium tuberculosis.